In order to promote the development of the overall technical level of experimental medicine and clinical diagnosis in my country's maternal and child health care system, accelerate the popularization and application of new technologies, and improve the level of diagnosis and treatment of women and children at the grassroots level, the China Maternal and Child Health Association was held in Nanchang, Jiangxi Province on May 24-26, 2019. hold"The Third China Conference on Women and Children's Clinical Diagnosis and Experimental Medicine."

The theme of this conference is "Regulation and Popularization, Innovation and Improvement", which aims to give full play to the spirit of industry associations to serve and promote the grassroots, popularize the application of advanced and suitable technologies at the grassroots, and drive the development of the entire industry.

The conference is divided into five sub-forums: Clinical Laboratory Forum, Molecular Diagnosis Forum, Clinical Blood Transfusion Forum, Young Scholar Forum, and Grassroots Maternal and Child Experimental Medicine Forum. Experts and scholars discussed important and difficult points in maternal and child health care from different fields, and provided diagnosis and treatment for women and children. Opened up new ideas.

Zhu Yuning, director of the Laboratory of Obstetrics and Gynecology Hospital of Zhejiang University School of Medicine, delivered a speech at the meeting, and proposed that biochemical and biophysical indicators can indicate more pregnancy risks and other abnormalities other than target chromosomal diseases. At the same time, prenatal screening and prenatal diagnosis The core technology layout of the company should be the forward movement of the prevention and control barrier.Director Zhu also expressed his concern about pregnancy-induced hypertension and preeclampsia, and explained the current academic and clinical research using multiple indicators to predict the risk and prevention of preeclampsia.

During the conference, Ao Cheng also attracted visits from the chairmen, vice-chairmen and chairpersons of various forums, and introduced our research and focus on maternal and child health. The effect of our PlGF detection reagent on preeclampsia has also been clinically diagnosed. With the approval of Professor Fu Qihua, chairman of the Experimental Medicine Branch.